Sunshine
| Cashflow Statement (Rs.'000') | 1Q23 | 2Q23 | 3Q23 | 4Q23 | 1Q24 | 2Q24 | 3Q24 | 4Q24 | - | FY22 | FY23 | FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre- tax profit | 2,007,724.9 | 2,004,182.3 | 973,193.5 | 675,537.0 | 1,866,131.0 | 2,797,926.0 | 2,446,612.0 | 961,216.0 | - | 5,646,673.4 | 5,660,637.6 | 8,071,886.0 |
| Interest Income | -54,216.1 | -412,997.0 | -125,948.5 | 115,356.0 | -388,074.0 | 103,280.0 | -94,183.0 | -146,336.0 | - | -366,448.5 | -477,805.5 | -525,313.0 |
| Profit on Disposal of Property, Plant & Equipment | -3,680.0 | -5,823.6 | -3,616.3 | -12,601.8 | -2,469.0 | -6,518.0 | -91.0 | 11,299.0 | - | -51,766.3 | -25,721.8 | 2,221.0 |
| Write-off of Intangible assets | 0.0 | 0.0 | 15.3 | -473.5 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | -458.2 | 0.0 |
| Biological assets-growing crops on bearer plants | 0.0 | -11,983.0 | 0.0 | -2,472.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | -19,718.0 | -14,455.0 | 0.0 |
| Impairment of Goodwill | 0.0 | 80,000.0 | 130,000.0 | 144,294.9 | 0.0 | 0.0 | 0.0 | 0.0 | - | 50,000.0 | 354,294.9 | 0.0 |
| Impairment losses and write downs on Bilogical assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 735.0 | 0.0 | 0.0 |
| Impairment/Write-off of Assets Held for Sale | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Impairment of investment in associates | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Fair value changes in Defferred consideration | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | -7,688.5 | 0.0 | 0.0 |
| Fair value changes in livestock | 0.0 | -5,382.0 | 0.0 | 162,822.0 | 0.0 | 7,845.0 | - | -37,277.0 | - | 6,013.0 | 157,440.0 | -29,432.0 |
| Interest Expense | -209,384.4 | 915,911.0 | 513,454.8 | 243,820.1 | 535,858.0 | -50,445.0 | 228,276.0 | 266,426.0 | - | 375,706.7 | 1,463,801.5 | 980,115.0 |
| Depreciation of property, plant and equipment and right-of-use assets | 188,148.9 | 142,584.7 | 119,307.9 | 337,956.5 | 183,851.0 | 183,313.0 | 188,474.0 | 215,460.0 | - | 644,735.0 | 787,998.0 | 771,098.0 |
| Amortisation | 20,753.2 | 19,613.7 | 41,475.8 | 5,211.9 | 20,940.0 | 21,114.0 | 21,460.0 | 28,700.0 | - | 52,863.4 | 87,054.6 | 92,214.0 |
| Depreciation of mature planations | 47,768.0 | 48,269.0 | 46,684.0 | 54,020.0 | 44,065.0 | 45,438.0 | 44,096.0 | 45,713.0 | - | 180,851.0 | 196,741.0 | 179,312.0 |
| Provision/(Reversal) for Bad and Doubtful Debts | 143,707.7 | 76,329.4 | -4,356.2 | -39,861.4 | 171,266.0 | 57,590.0 | 27,855.0 | 61,918.0 | - | 90,581.0 | 175,819.5 | 318,629.0 |
| Provision/ (Reversal) of impairment of inventories | 58,717.2 | -10,163.7 | 20,356.0 | 85,846.6 | -32,527.0 | -31,856.0 | -79,125.0 | 247,447.0 | - | 21,616.4 | 154,756.0 | 103,939.0 |
| Profit/(loss) of equity investee | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 436.6 | 0.0 | 0.0 |
| Amortisation of Deferred Income | -589.0 | -590.0 | 709.6 | -1,888.6 | -590.0 | -589.0 | -590.0 | -589.0 | - | -50,554.0 | -2,358.0 | -2,358.0 |
| Amortization of Lesehold land right | 3,035.0 | 3,219.0 | 3,004.0 | 91,674.0 | 5,602.0 | 2,700.0 | 60.0 | 9,174.0 | - | 11,298.0 | 100,932.0 | 17,536.0 |
| Fair value gain/loss on investments | 6,252.5 | -2,355.4 | 4,821.8 | 31,269.7 | -1,310.0 | -5,486.0 | -177.0 | 13,325.0 | - | 13,989.0 | 39,988.7 | 6,352.0 |
| Provision for Gratuity excluding acturial gain/loss | 24,484.7 | 48,093.6 | 21,663.5 | 68,616.8 | 28,589.0 | 26,791.0 | 27,351.0 | 152,887.0 | - | 108,571.3 | 162,858.6 | 235,618.0 |
| Timber Fair Valuation Gain | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Rent Concession | 0.0 | -2,910.6 | -618.8 | -1,075.6 | 0.0 | 0.0 | 0.0 | 0.0 | - | -14,221.1 | -4,605.0 | 0.0 |
| Fair value gain/loss on Consumer Biological Assets | 0.0 | 0.0 | 0.0 | -10,486.0 | 0.0 | 5,795.0 | 0.0 | -16,353.0 | - | -1,328.0 | -10,486.0 | -10,558.0 |
| Loss/ (Gain) on disposal of Subsidiary | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 2,705.8 | 0.0 | 0.0 |
| Fair value gain on investment property | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | -241,076.3 | 0.0 | 0.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Operating profit before working capital changes | 2,232,722.5 | 2,885,997.3 | 1,740,146.5 | 1,947,566.5 | 2,431,332.0 | 3,156,898.0 | 2,810,018.0 | 1,813,010.0 | - | 6,453,974.8 | 8,806,432.8 | 10,211,259.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| (Increase)/decrease in inventories | -2,900,329.6 | -261,827.9 | 860,182.9 | 39,207.0 | -40,913.0 | -373,511.0 | -1,520,555.0 | -371,128.0 | - | -1,360,072.8 | -2,262,767.7 | -2,306,107.0 |
| (Increase)/decrease in trade and other receivables | -1,708,311.6 | -521,365.1 | -1,394,975.0 | 2,571,001.4 | -1,194,625.0 | -1,212,950.0 | -1,635,954.0 | 1,834,675.0 | - | -1,278,898.7 | -1,053,650.3 | -2,208,854.0 |
| (Increase)/decrease in amounts due from related parties | -69,962.4 | 35,296.7 | 8,162.4 | -79,750.3 | -5,367.0 | -177,041.0 | 234,225.0 | 51,876.0 | - | -10,180.3 | -106,253.6 | 103,693.0 |
| Increase/(decrease) in trade and other payables | 3,095,733.0 | -2,498,357.2 | 55,667.7 | -646,901.0 | 2,591,434.0 | -1,165,570.0 | 362,509.0 | -594,808.0 | - | 1,872,280.1 | 6,142.5 | 1,193,565.0 |
| Increase/(decrease) in amounts due to related parties | -65,727.8 | 186,908.5 | -186,908.5 | 55,000.0 | 1,099.0 | -55,189.0 | 1.0 | -911.0 | - | 94,380.9 | -10,727.8 | -55,000.0 |
| (Increase)/decrease in prepayments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Cash generated from / (used in) operations | 584,124.1 | -173,347.7 | 1,082,276.0 | 3,886,123.6 | 3,782,960.0 | 172,637.0 | 250,244.0 | 2,732,714.0 | - | 5,771,484.1 | 5,379,176.0 | 6,938,556.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Interest paid | -160,564.5 | -447,888.2 | -471,662.7 | -282,134.6 | -452,068.0 | 117,919.0 | -177,062.0 | 16,524.0 | - | -283,774.2 | -1,362,250.0 | -494,687.0 |
| Income tax paid | -444,683.6 | -822,093.2 | -217,272.7 | -460,063.2 | -470,105.0 | -617,417.0 | -670,407.0 | -468,619.0 | - | -870,194.3 | -1,944,112.6 | -2,226,548.0 |
| Gratuity paid | -17,272.1 | -19,926.8 | -45,551.7 | 16,296.6 | -20,933.0 | -31,723.0 | -43,149.0 | -37,821.0 | - | -74,001.8 | -66,454.1 | -133,626.0 |
| Net cash flow from / (used in) operating activities | -38,396.1 | -1,463,256.0 | 347,789.0 | 3,160,222.4 | 2,839,854.0 | -358,584.0 | -640,374.0 | 2,242,798.0 | - | 4,543,513.7 | 2,006,359.4 | 4,083,695.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Cash flows from/(used in) investing activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Interest Received | 52,175.1 | 419,304.3 | 115,740.2 | -109,414.0 | 388,074.0 | -103,280.0 | 94,183.0 | 146,336.0 | - | 356,021.5 | 477,805.5 | 525,313.0 |
| (Investments)/ Disposal in Other Investments | -10,487.2 | -134,512.8 | 10,052.6 | 207,661.6 | 850,408.0 | 34,711.0 | 2,999.0 | -5,881.0 | - | -101,136.7 | 72,714.2 | 882,237.0 |
| (Investments)/ Disposal in Short term Investments | 580,381.6 | 133,062.0 | -20,280.0 | -1,059,456.8 | -478.0 | -776,764.0 | -68,462.0 | -694,682.0 | - | -397,365.2 | -366,293.2 | -1,540,386.0 |
| (Investments)/ Disposal in gratuity fund | 1.0 | 5,800.0 | 17,886.0 | -4,657.0 | 9,000.0 | 0.0 | 0.0 | 0.0 | - | 87,800.0 | 19,030.0 | 9,000.0 |
| Additions to Bearer plants | -34,321.0 | -2,481.0 | -30,826.0 | 3,576.0 | -10,343.0 | -11,770.0 | -13,264.0 | -644.0 | - | -169,818.0 | -64,052.0 | -36,021.0 |
| Acquisition of live stock | -34,543.0 | -35,457.0 | -39,300.0 | -55,876.0 | -52,918.0 | -58,926.0 | -69,858.0 | -124,507.0 | - | -225,695.0 | -165,176.0 | -306,209.0 |
| Acquisition of property, plant and equipment | -504,626.7 | -146,126.7 | -225,898.1 | -625,847.0 | -107,555.0 | -260,878.0 | -197,613.0 | -148,749.0 | - | -918,782.4 | -1,502,498.5 | -714,795.0 |
| Acquisition of Intangible Assets | -1,759.1 | -9,557.4 | -29,980.1 | 1,161.5 | -5,910.0 | -3,800.0 | -8,303.0 | -2,993.0 | - | -189,734.5 | -40,135.1 | -21,006.0 |
| Disposal/ (Additions) to Consumable biological assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Proceeds from Disposal of PPE | 6,130.0 | 23,428.0 | 187,765.4 | 254,836.7 | 4,965.0 | 6,518.0 | 369.0 | 18,269.0 | - | 66,368.2 | 472,160.1 | 30,121.0 |
| Proceeds from sales of livestock | 11,089.0 | 14,116.0 | 16,736.0 | 15,929.0 | 11,608.0 | 17,649.0 | 10,745.0 | 23,120.0 | - | 25,821.0 | 57,870.0 | 63,122.0 |
| Disposal of investment in associates | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 93,000.0 | 0.0 | 0.0 | - | 900.0 | 0.0 | 93,000.0 |
| Acquisition of Noncontrolling interest in Subsidiaries | 0.0 | -461,780.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | -400,000.0 | -461,780.5 | 0.0 |
| Acquisition of Subsidiaries (net of cash) | -1,563,683.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | -1,563,683.8 | 0.0 |
| Disposal of Subsidiary (net of cash) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 645,479.8 | 0.0 | 0.0 |
| Defferred consideration paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | -70,337.9 | 0.0 | 0.0 |
| Net Proceeds from Disposal of Biological Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 402.0 | 0.0 | 0.0 |
| Acquisition of Investment property | -915.5 | 0.0 | -1,119.4 | -11,257.9 | 0.0 | -3,685.0 | 0.0 | 0.0 | - | -19,518.1 | -13,292.9 | -3,685.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Cash Flows from Investing Activities | -1,500,559.6 | -194,205.2 | 776.5 | -1,383,343.9 | 1,086,851.0 | -1,067,225.0 | -249,204.0 | -789,731.0 | - | -1,309,595.1 | -3,077,332.1 | -1,019,309.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Cash flows from/(used in) financing activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Proceeds from financing | 3,176,639.3 | 3,103,425.5 | 4,650,818.4 | 2,771,158.1 | 6,891,928.0 | -4,154,569.0 | 1,156,523.0 | 302,015.0 | - | 4,731,267.6 | 13,702,041.4 | 4,195,897.0 |
| Proceeds from share Issued by subsidiaries to NCI | 0.0 | 0.0 | 0.0 | 196,000.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 355,940.0 | 196,000.0 | 0.0 |
| Advance received from NCI (APHL) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 10,000.0 | 0.0 | 0.0 |
| Repayment of financing | -2,534,350.5 | -1,314,223.3 | -4,874,360.8 | -3,744,888.4 | -7,684,420.0 | 4,830,890.0 | -236,206.0 | 131,510.0 | - | -6,025,277.5 | -12,467,823.0 | -2,958,226.0 |
| Payment to lease creditor | 35,567.2 | -80,541.6 | -6,489.6 | -37,401.2 | -25,981.0 | 9,189.0 | -42,779.0 | -108,282.0 | - | -65,024.0 | -88,865.2 | -167,853.0 |
| Dividend Paid | -664,958.9 | -519,000.0 | -432,709.5 | 0.0 | -754,176.0 | -275,000.0 | -1,393,769.0 | -18.0 | - | -1,601,556.9 | -1,616,668.4 | -2,422,963.0 |
| Net cash flows from / (used in) financing activities | 12,897.2 | 1,189,660.6 | -662,741.5 | -815,131.4 | -1,572,649.0 | 410,510.0 | -516,231.0 | 325,225.0 | - | -2,594,650.9 | -275,315.1 | -1,353,145.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Net increase in cash and cash equivalents | -1,526,058.4 | -467,800.5 | -314,176.0 | 961,747.0 | 2,354,056.0 | -1,015,299.0 | -1,405,809.0 | 1,778,292.0 | - | 639,267.7 | -1,346,287.9 | 1,716,247.0 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,338,757.0 | 0.0 | 0.0 | - | 0.0 | 0.0 | 0.0 |
| Cash and CE at start | 2,347,210,022.0 | 825,395,932.0 | 405,927,073.0 | 45,935.8 | 1,001,633.0 | 3,352,999.0 | 2,338,545.0 | 933,456.0 | - | 1,698,437,024.0 | 2,347,210.0 | 1,001,633.4 |
| Effect of exchange rate changes on cash and cash equivalents | 4,244.3 | -1,668.4 | 4,184.7 | -6,049.4 | -2,690.0 | 845.0 | 720.0 | -2,210.0 | - | 9,505.9 | 711.2 | -3,335.0 |
| Cash and CE at end | 2,345,688,207.9 | 824,926,463.1 | 405,617,081.7 | 1,001,633.4 | 3,352,999.0 | 2,338,545.0 | 933,456.0 | 2,709,538.0 | - | 1,699,085,797.6 | 1,001,633.4 | 2,714,545.4 |